Oral Mineralocorticoid Receptor Antagonists for the Treatment of CSC
EHSAN RAHIMY, MD • JOHN D. PITCHER, III, MD • MITCHELL S. FINEMAN, MD • JASON HSU, MD
Long-term CSC can be treated orally.
Frequently Asked Questions About Subthreshold Laser Therapy
JAY CHHABLANI, MD • JEFFREY K. LUTTRULL, MD • SOBHA SIVAPRASAD, DM, FRCOphth, FRCS DANIEL LAVINSKY, MD • SAM E. MANSOUR, MSc, MD, FRCS(C), FACS
The second part of a roundtable discussion about treatment modalities
Vitrectomy for Diabetic Macular Edema
MAURICE B. LANDERS, III, MD; MICHAEL W. STEWART, MD; DAVID J. BROWNING, MD, PhD; TOSHINORI MURATA, MD, PhD; MATT OHJI, MD; HUGO QUIROZ-MERCADO, MD; JAY CHHABLANI, MD; JERZY NAWROCKI, MD, PhD; VERONICA KON GRAVERSON, MD; MARIE S. VOGEL, BS, MS
It reduces DME, is as safe as series of injections, and costs much less.
Current Concepts of ICG Angiography for Evaluation of CNV
RYAN B. RUSH, MD • SLOAN W. RUSH, MD
Indocyanine green is particularly suited for detection.
Using IRIS Data to Set Benchmarks for Retina Patients
NIVA DORELL, CONTRIBUTING EDITOR
AAO provides unprecedented access to clinical data.
Peter K. Kaiser, MD
BY JERRY HELZNER, CONTRIBUTING EDITOR
Innovation in Retina
EDITED BY EMMETT T. CUNNINGHAM, JR., MD, PhD, MPH, AND PRAVIN U. DUGEL, MD
Dr. Joan W. Miller of Mass Eye and Ear
NEW PRODUCT APPLICATIONS
BY KAREN APPOLD, CONTRIBUTING WRITER
Improving Screening for Diabetic Retinopathy